The present invention relates to a method for providing information on fetal diseases associated with a functional neurological disorder due to maternal epilepsy during pregnancy and a screening method for therapeutic agents for such diseases. More particularly, the present invention relates to a method for providing information on functional, fetal neurological disorders by identifying the expression patterns of GABAB1 receptor, PKA, cytochrome-C, or caspase-3 in fetal hippocampal neurons from an individual with suspected epilepsy and a normal individual, and a screening method for therapeutic agents for diseases associated with functional neurological disorders, which comprises administering a candidate agent to a suitable model for maternal epileptic seizure and identifying increase or decrease in specific protein expressions.
DIAGNOSTIC METHOD FOR FETAL NEUROLOGICAL DISORDERS DUE TO MATERNAL EPILEPSY AND SCREENING METHOD FOR THERAPEUTIC AGENTS THEREFOR